News
The T7+ integrates MGI's proprietary DNBSEQ™ technology with next-generation fluidics, optics, and bioinformatics, creating a platform that is faster, smarter, and more versatile than ever before. The ...
Google's DeepMind CEO Demis Hassabis says the most valuable human skill for the future will be “learning how to learn” as artificial intelligence transforms education, careers and daily life ...
Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.
Tumor immunotherapies, especially those leveraging T-cells to identify and eliminate cancer cells, represent a major ...
Vietnam Investment Review on MSN
Zentrogene Hong Kong Twin DNA Test 2025 99 Early Gender Accuracy
HONG KONG SAR - Media OutReach Newswire - 12 September 2025 - Zentrogene Laboratory, an international genetic testing institution based in Hong Kong (under Sanai Health Industry Group 01889.HK), ...
HONG KONG SAR - Media OutReach Newswire - 12 September 2025 - Zentrogene Laboratory, an international genetic testing institution based in Hong Kong (under Sanai Health Industry Group 01889.HK), annou ...
LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- What Is The Omics-Based Clinical Trials Market Size And Growth? In recent times, the omics-based clinical trials market ...
IBASE Technology Inc. (TPEx: 8050), a leading provider of rugged embedded computing solutions, introduces the MPT-7100R, its ...
Zacks Investment Research on MSN
ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay
Illumina, Inc. ILMN recently announced the launch of Illumina Protein Prep, an assay designed to deliver superior performance for next-generation sequencing (NGS)-based proteomics discovery at scale.
Discover why Fulgent’s accelerating revenue and rising margins signal growth potential, with shares undervalued vs. cash.
Revenue generated from pharma research and development services was RMB45.2 million (US$6.3 million) for the three months ended June 30, 2025, representing a 68.1% increase from RMB26.9 million for ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results